106 related articles for article (PubMed ID: 2555061)
21. Expression of selected genes and oncogenes in differentiated HL-60 cells and primary cells from human leukemias.
Shiosaka T; Tanaka Y
Anticancer Res; 1989; 9(5):1249-64. PubMed ID: 2589822
[TBL] [Abstract][Full Text] [Related]
22. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells.
Sugie T; Kubota H; Sato M; Nakamura E; Imamura M; Minato N
J Immunol; 1996 Nov; 157(9):3925-35. PubMed ID: 8892624
[TBL] [Abstract][Full Text] [Related]
23. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.
Flavell DJ; Boehm DA; Noss A; Warnes SL; Flavell SU
Br J Cancer; 2001 Feb; 84(4):571-8. PubMed ID: 11207056
[TBL] [Abstract][Full Text] [Related]
24. Comparison of T cell receptor alpha, beta, and gamma gene rearrangement and expression in T cell acute lymphoblastic leukemia.
Hara J; Benedict SH; Champagne E; Mak TW; Minden M; Gelfand EW
J Clin Invest; 1988 Apr; 81(4):989-96. PubMed ID: 3162460
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a novel malignant B cell line with t(14;18) and t(4;11) established from a patient with acute monoblastic leukemia.
de Kroon JF; Kluin-Nelemans HC; Kluin PM; Schuuring E; van Bergen CA; Oving I; Wessels H; Willemze R; Falkenburg JH
Exp Hematol; 1997 Sep; 25(10):1062-8. PubMed ID: 9293903
[TBL] [Abstract][Full Text] [Related]
26. Methods of immunosuppression for study of growth and lung colony formation by human tumor cells in mice.
Kovnat A; Khoo K; Selby P; Tannock I
Cancer Res; 1986 Apr; 46(4 Pt 1):1617-22. PubMed ID: 3512076
[TBL] [Abstract][Full Text] [Related]
27. Engraftment of human T-cell acute lymphoblastic leukemia in immunodeficient NOD/SCID mice which have been preconditioned by injection of human cord blood.
Dialynas DP; Shao L; Billman GF; Yu J
Stem Cells; 2001; 19(5):443-52. PubMed ID: 11553853
[TBL] [Abstract][Full Text] [Related]
28. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
[TBL] [Abstract][Full Text] [Related]
29. Induction of transforming growth factor beta 1 and its receptor expression during myeloid leukemia cell differentiation.
Taipale J; Matikainen S; Hurme M; Keski-Oja J
Cell Growth Differ; 1994 Dec; 5(12):1309-19. PubMed ID: 7696179
[TBL] [Abstract][Full Text] [Related]
30. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
31. Effects of stem cell factor on the growth and radiation survival of tumor cells.
Shui C; Khan WB; Leigh BR; Turner AM; Wilder RB; Knox SJ
Cancer Res; 1995 Aug; 55(15):3431-7. PubMed ID: 7542170
[TBL] [Abstract][Full Text] [Related]
32. Xenografts of human bladder cancer in immune-deprived mice.
Kovnat A; Armitage M; Tannock I
Cancer Res; 1982 Sep; 42(9):3696-703. PubMed ID: 7049361
[TBL] [Abstract][Full Text] [Related]
33. A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell line.
Cinti C; Claudio PP; Luca AD; Cuccurese M; Howard CM; D'Esposito M; Paggi MG; Sala DL; Azzoni L; Halazonetis TD; Giordano A; Maraldi NM
Oncogene; 2000 Oct; 19(44):5098-105. PubMed ID: 11042698
[TBL] [Abstract][Full Text] [Related]
34. Development and characterization of v-myc/v-raf-transformed murine fetal thymocyte cell lines.
Taubenberger JK; Reid AH; Izon D; Boehme SA
Cell Immunol; 1996 Jul; 171(1):41-7. PubMed ID: 8754860
[TBL] [Abstract][Full Text] [Related]
35. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
36. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
Haber M; Norris MD; Kavallaris M; Bell DR; Davey RA; White L; Stewart BW
Cancer Res; 1989 Oct; 49(19):5281-7. PubMed ID: 2569932
[TBL] [Abstract][Full Text] [Related]
37. Thy-1+ epidermal cells in nude mice are distinct from their counterparts in thymus-bearing mice. A study of morphology, function, and T cell receptor expression.
Nixon-Fulton JL; Kuziel WA; Santerse B; Bergstresser PR; Tucker PW; Tigelaar RE
J Immunol; 1988 Sep; 141(6):1897-903. PubMed ID: 2902136
[TBL] [Abstract][Full Text] [Related]
38. Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia.
Uno S; Kinoshita Y; Azuma Y; Tsunenari T; Yoshimura Y; Iida S; Kikuchi Y; Yamada-Okabe H; Fukushima N
Oncol Rep; 2007 May; 17(5):1189-94. PubMed ID: 17390064
[TBL] [Abstract][Full Text] [Related]
39. Human T-cell lymphoblastic lymphoma expressing the T-cell receptor gamma/delta established in immune-deficient (bg/nu/xid) mice.
Biondi A; Motta T; Garofalo A; Rossi V; Giudici G; Rizzo V; Pioltelli P; Corneo G; Barbui T; Parma A
Leukemia; 1993 Feb; 7(2):281-9. PubMed ID: 8381196
[TBL] [Abstract][Full Text] [Related]
40. Characterization of an interleukin-2 dependent human leukemic cell line, PER-315, with an immature T cell phenotype which does not express the tac antigen.
Kees UR; Ford J; Ranford PR; Dawson VM
Leukemia; 1990 Apr; 4(4):292-6. PubMed ID: 2164120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
